178 related articles for article (PubMed ID: 8137734)
1. Effects of 1,25-dihydroxyvitamin D3 on proliferation and differentiation of Caco-2 cells.
Halline AG; Davidson NO; Skarosi SF; Sitrin MD; Tietze C; Alpers DH; Brasitus TA
Endocrinology; 1994 Apr; 134(4):1710-7. PubMed ID: 8137734
[TBL] [Abstract][Full Text] [Related]
2. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.
Zhao X; Feldman D
Endocrinology; 1993 Apr; 132(4):1808-14. PubMed ID: 8384998
[TBL] [Abstract][Full Text] [Related]
3. 1,25(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25(OH)2D3 receptor in HL-60 cells and related subclones.
Taoka T; Collins ED; Irino S; Norman AW
Mol Cell Endocrinol; 1993 Sep; 95(1-2):51-7. PubMed ID: 8243807
[TBL] [Abstract][Full Text] [Related]
4. Treatment of resting zone chondrocytes with 24,25-dihydroxyvitamin D3 [24,25-(OH)2D3] induces differentiation into a 1,25-(OH)2D3-responsive phenotype characteristic of growth zone chondrocytes.
Schwartz Z; Dean DD; Walton JK; Brooks BP; Boyan BD
Endocrinology; 1995 Feb; 136(2):402-11. PubMed ID: 7530645
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation.
Giuliano AR; Franceschi RT; Wood RJ
Arch Biochem Biophys; 1991 Mar; 285(2):261-9. PubMed ID: 1654769
[TBL] [Abstract][Full Text] [Related]
6. The E1A oncogene induces resistance to the effects of 1,25-dihydroxyvitamin D3 on inhibition of growth of mouse keratinocytes.
Park K; Bae H; Heydemann A; Roberts AB; Dotto GP; Sporn MB; Kim SJ
Cancer Res; 1994 Dec; 54(23):6087-9. PubMed ID: 7954451
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
Nagasaki T; Hino M; Inaba M; Nishizawa Y; Morii H; Otani S
Arch Biochem Biophys; 1997 Jul; 343(2):181-7. PubMed ID: 9224728
[TBL] [Abstract][Full Text] [Related]
8. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
Levy Y; Knutson JC; Bishop C; Shany S
Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
[TBL] [Abstract][Full Text] [Related]
9. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.
Koizumi T; Nakao Y; Ishizuka S; Oshida J; Hara N; Ikekawa N; Fijita T
Arch Biochem Biophys; 1990 Feb; 276(2):310-6. PubMed ID: 2407190
[TBL] [Abstract][Full Text] [Related]
10. 1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells.
Mitsuhashi T; Morris RC; Ives HE
J Clin Invest; 1991 Jun; 87(6):1889-95. PubMed ID: 1645744
[TBL] [Abstract][Full Text] [Related]
11. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1993 May; 132(5):1952-60. PubMed ID: 7682937
[TBL] [Abstract][Full Text] [Related]
13. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
Sterck JG; Klein-Nulend J; Burger EH; Lips P
J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947
[TBL] [Abstract][Full Text] [Related]
14. Effect of 1,25-dihydroxyvitamin D3 on induction of scavenger receptor and differentiation of 12-O-tetradecanoylphorbol-13-acetate-treated THP-1 human monocyte like cells.
Suematsu Y; Nishizawa Y; Shioi A; Hino M; Tahara H; Inaba M; Morii H; Otani S
J Cell Physiol; 1995 Dec; 165(3):547-55. PubMed ID: 7593234
[TBL] [Abstract][Full Text] [Related]
15. 1,25(OH)2D3 and dihydrotestosterone interact to regulate proliferation and differentiation of epiphyseal chondrocytes.
Krohn K; Haffner D; Hügel U; Himmele R; Klaus G; Mehls O; Schaefer F
Calcif Tissue Int; 2003 Oct; 73(4):400-10. PubMed ID: 12874696
[TBL] [Abstract][Full Text] [Related]
16. Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells.
Yoshida M; Tanaka Y; Eguchi T; Ikekawa N; Saijo N
Anticancer Res; 1992; 12(6B):1947-52. PubMed ID: 1363510
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on proliferation and vitamin D receptor expression of rat growth cartilage cells.
Klaus G; von Eichel B; May T; Hügel U; Mayer H; Ritz E; Mehls O
Endocrinology; 1994 Oct; 135(4):1307-15. PubMed ID: 7523093
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress, cell cycle arrest and differentiation contribute toward the antiproliferative action of BSO and calcitriol on Caco-2 cells.
Liaudat AC; Bohl LP; Tolosa de Talamoni NG; Maletto B; Pistoresi-Palencia MC; Picotto G
Anticancer Drugs; 2014 Aug; 25(7):810-8. PubMed ID: 24681551
[TBL] [Abstract][Full Text] [Related]
19. 1 alpha,25-dihydroxyvitamin D3 inhibits cell growth and chondrogenesis of a clonal mouse EC cell line, ATDC5.
Akiyama H; Hiraki Y; Shigeno C; Kohno H; Shukunami C; Tsuboyama T; Kasai R; Suzuki F; Konishi J; Nakamura T
J Bone Miner Res; 1996 Jan; 11(1):22-8. PubMed ID: 8770693
[TBL] [Abstract][Full Text] [Related]
20. 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs.
Musiol IM; Feldman D
Endocrinology; 1997 Jan; 138(1):12-8. PubMed ID: 8977379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
